Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assaysZhe Hu(National Institute of Allergy and Infectious Diseases), Julie M. Fox(National Institutes of Health)Proceedings of the National Academy of SciencesJuly 8, 202410.1073/pnas.2310421121Cited by 12SaveCiteExport RISWatch citationsRelated PapersBroadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress|Cell|2015|218Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis|Cell Reports|2015|113